Advertisement

Topics

Moody's cuts Teva debt to junk status

06:26 EST 14 Jan 2018 | Globes

"The downgrade of Teva's ratings to speculative grade reflects the challenge of managing its significant debt burden while facing a prolonged period of earnings erosion."

Original Article: Moody's cuts Teva debt to junk status

NEXT ARTICLE

More From BioPortfolio on "Moody's cuts Teva debt to junk status"

Quick Search
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Ad Here